Thyroid News

The first patient has been enrolled in a phase 4 clinical trial to evaluate the safety and efficacy of Tepezza in patients with chronic thyroid eye disease, according to a press release from Horizon Therapeutics.

Molecular testing was the best predictor for malignancy in indeterminate thyroid nodules when compared with clinical factors, according to findings from a post hoc analysis published in Thyroid.

Subclinical hypothyroidism and hyperthyroidism are not associated with cognitive function, cognitive decline or dementia, according to an analysis of data of more than 74,000 people from 23 cohorts published in JAMA Internal Medicine.

Adults with differentiated thyroid cancer who undergo thyroidectomy are at increased risks for atrial fibrillation, cardiovascular disease, increased heart rate and left ventricular mass development, data from a review show.

Women are about four times more likely than men to be diagnosed with papillary thyroid cancer during their lifetime, even though the prevalence of thyroid cancer at autopsy is roughly the same in men and women, according to study findings.

More than two-thirds of adults who underwent surgery for benign thyroid disease at a California health center were eligible for thyroid radiofrequency ablation, according to study findings published in Surgery.

Eating more foods that are high in protein and saturated fatty acids is associated with better thyroid function, according to findings from a cross-sectional study published in Nutrition.

Among adults with differentiated thyroid cancer on thyroid-stimulating hormone suppression therapy, postmenopausal women had lower bone mineral density at the lumbar spine whereas premenopausal women had greater BMD vs. healthy controls.

For my inaugural post for this blog in November 2016, I wrote about the spectacular sight of the closest full supermoon since January 1948. It was a special occasion for me, generally and personally.

The FDA granted priority review to cabozantinib for treatment of certain patients with differentiated thyroid cancer.